<DOC>
	<DOCNO>NCT01664520</DOCNO>
	<brief_summary>The purpose study investigate dexmedetomidine affect static dynamic autoregulation , intracranial pressure ( ICP ) cerebral oxygenation aneurysmal subarachnoid haemorrhage ( SAH ) patient .</brief_summary>
	<brief_title>Dexmedetomidine Subarachnoid Haemorrhage</brief_title>
	<detailed_description>Dexmedetomidine selective Î±2-agonist induces sedation , anxiolysis analgesia without respiratory depression . These effect , well neuroprotective property experimental study would ideal neuroanaesthesia neurocritical care . Poor grade SAH patient treat intensive care unit ( ICU ) . These patient sedate often propofol . However , assess patient 's neurology , propofol sedation must stop waken patient may take time . Dexmedetomidine would advantageous , allow waken infusion . However , effect dexmedetomidine cerebral autoregulation unknown SAH patient . 15 SAH patient require sedation , mechanical ventilation ICP monitoring roll study .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Aneurysmal SAH Aneurysm treat coil ( ) clip ( ) Age 1880 year Written inform consent next kin Pregnancy Nursing woman Sick sinus syndrome Carotid stenosis Heart rate le 50 beat / minute Mean arterial pressure le 50 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Subarachnoid hemorrhage</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Autoregulation</keyword>
	<keyword>Intracranial pressure</keyword>
	<keyword>Cerebral oxygenation</keyword>
</DOC>